CompletedNot Applicable

Epidemiological Study in FRONtoTemporal Dementia

Belgium, Germany2,287 participantsStarted 2021-09-01

Plain-language summary

An international, multicenter, epidemiological observational study aims to investigate the prevalence of genetic etiologies in patients diagnosed with FTD or clinically suspected for FTD.

Who can participate

Age range25 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Informed consent, which includes reference to the genetic testing, is obtained from the participant/legal guardian * The participant is aged between 25 to 85 years * The participant is diagnosed with Frontotemporal dementia (FTD) or has signs or symptoms of FTD

What they're measuring

To investigate the prevalence of genetic etiologies in FTD by genotyping FTD participants/ FTD suspected participants

Timeframe: 15 months

Trial details

NCT IDNCT05075187

SponsorCENTOGENE GmbH Rostock

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2024-01-09

View on ClinicalTrials.gov More Frontotemporal Dementia trials